Dehydroepiandrosterone 75mg SR Tablet in PCD pharma franchise in Maharashtra

Dehydroepiandrosterone 75mg SR Tablet in pharma manufacturing company in Delhi

Dehydroepiandrosterone 75mg SR Tablet in hormonal care pharma franchise in India

Dehydroepiandrosterone 75mg SR Tablet in PCD pharma suppliers in Bangalore

Dehydroepiandrosterone 75mg SR Tablet in pharma distributor in Mumbai
Dehydroepiandrosterone 75mg SR Tablet in pharma export companies in India

Home/Products /dehydroepiandrosterone-75-sr-tablet

Ovaflip SR Tablet

Composition : Dehydroepiandrosterone 75 SR

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹390/-

Ovaflip is a specialized formulation containing Dehydroepiandrosterone (DHEA) in a sustained-release (SR) format, designed to support hormonal balance and overall well-being. DHEA is a naturally occurring hormone produced by the adrenal glands, playing a crucial role in the synthesis of other hormones, including testosterone and estrogen. As individuals age, DHEA levels tend to decline, which can lead to various health issues. Ovaflip aims to replenish these levels, potentially enhancing energy, mood, and cognitive function.

The sustained-release mechanism of Ovaflip ensures a gradual release of DHEA into the bloodstream, providing a more stable and prolonged effect compared to immediate-release formulations. This can be particularly beneficial for individuals seeking to manage symptoms associated with hormonal imbalances, such as fatigue, mood swings, and decreased libido.

In addition to its hormonal benefits, DHEA has been studied for its potential therapeutic effects in various medical fields. It may play a role in supporting cardiovascular health, enhancing immune function, and improving overall vitality. Ovaflip is particularly relevant in the fields of endocrinology and gynecology, where hormonal regulation is essential for reproductive health and metabolic function.

Read More

About the Product

Ovaflip is a specialized formulation containing Dehydroepiandrosterone (DHEA) in a sustained-release (SR) format, designed to support hormonal balance and overall well-being. DHEA is a naturally occurring hormone produced by the adrenal glands, playing a crucial role in the synthesis of other hormones, including testosterone and estrogen. As individuals age, DHEA levels tend to decline, which can lead to various health issues. Ovaflip aims to replenish these levels, potentially enhancing energy, mood, and cognitive function.

The sustained-release mechanism of Ovaflip ensures a gradual release of DHEA into the bloodstream, providing a more stable and prolonged effect compared to immediate-release formulations. This can be particularly beneficial for individuals seeking to manage symptoms associated with hormonal imbalances, such as fatigue, mood swings, and decreased libido.

In addition to its hormonal benefits, DHEA has been studied for its potential therapeutic effects in various medical fields. It may play a role in supporting cardiovascular health, enhancing immune function, and improving overall vitality. Ovaflip is particularly relevant in the fields of endocrinology and gynecology, where hormonal regulation is essential for reproductive health and metabolic function.

Common side effects may include acne, hair loss, and changes in menstrual cycle. Consult a healthcare professional for a complete list of potential side effects.

Ovaflip is indicated for individuals experiencing symptoms related to low DHEA levels, including fatigue, mood disturbances, and decreased libido. It may also be beneficial for those seeking to support their overall hormonal health.

Consult a healthcare provider before starting Ovaflip, especially if you have a medical condition or are taking other medications.

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation